BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15541419)

  • 1. Increased release of immunoreactive dynorphin A1-17 from the spinal cord after intrathecal treatment with endomorphin-2 in anesthetized rats.
    Leitermann RJ; Terashvili M; Mizoguchi H; Wu HE; Chen F; Clithero A; Tseng LF
    Eur J Pharmacol; 2004 Nov; 504(3):177-83. PubMed ID: 15541419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
    Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat.
    Terashvili M; Wu HE; Leitermann RJ; Sun HS; Clithero AD; Tseng LF
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1257-65. PubMed ID: 15542622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
    Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat.
    Terashvili M; Wu HE; Schwasinger E; Tseng LF
    Eur J Pharmacol; 2007 Jan; 554(2-3):137-44. PubMed ID: 17112504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
    Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T
    Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of [Met5]enkephalin from the spinal cord by intraventricularly administered endomorphin-2, but not endomorphin-1 in the anesthetized rat.
    Ohsawa M; Shiraki M; Mizoguchi H; Narita M; Kawai K; Nagase H; Cheng EY; Narita M; Tseng LF
    Neurosci Lett; 2001 Dec; 316(1):1-4. PubMed ID: 11720764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
    Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
    Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M; Mizoguchi H; Narita M; Nagase H; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2001 Aug; 298(2):592-7. PubMed ID: 11454920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of spinal mu(1)-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar.
    Mizoguchi H; Ito K; Watanabe H; Watanabe C; Katsuyama S; Fujimura T; Sakurada T; Sakurada S
    Peptides; 2006 Nov; 27(11):2786-93. PubMed ID: 16919848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the μ opioid receptor and enkephalin to the antinociceptive actions of endomorphin-1 analogs with unnatural amino acid modifications in the spinal cord.
    Zhou J; Zhao L; Wei S; Wang Y; Zhang X; Ma M; Wang K; Liu X; Wang R
    Peptides; 2021 Jul; 141():170543. PubMed ID: 33794284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of synchronous or asynchronous electroacupuncture stimulation with low versus high frequency on spinal opioid release and tail flick nociception.
    Wang Y; Zhang Y; Wang W; Cao Y; Han JS
    Exp Neurol; 2005 Mar; 192(1):156-62. PubMed ID: 15698629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered opioid-mediated control of the spinal release of dynorphin and met-enkephalin in polyarthritic rats.
    Ballet S; Mauborgne A; Hamon M; Cesselin F; Collin E
    Synapse; 2000 Sep; 37(4):262-72. PubMed ID: 10891863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropeptide FF analogue, 1DMe, reduces in vivo dynorphin release from the rat spinal cord.
    Ballet S; Braz J; Mauborgne A; Bourgoin S; Zajac JM; Hamon M; Cesselin F
    J Neurochem; 2002 May; 81(3):659-62. PubMed ID: 12065675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively.
    Okutsu H; Watanabe S; Takahashi I; Aono Y; Saigusa T; Koshikawa N; Cools AR
    Neuropsychopharmacology; 2006 Feb; 31(2):375-83. PubMed ID: 16034447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.
    Tseng LF; Narita M; Suganuma C; Mizoguchi H; Ohsawa M; Nagase H; Kampine JP
    J Pharmacol Exp Ther; 2000 Feb; 292(2):576-83. PubMed ID: 10640294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.